Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy-Reference-Cited by-同舟云学术

Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy

Published:2022-10 Issue:10 Volume:28 Page:694.e1-694.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Winters Amanda C.^ORCID,Bosma Grace^ORCID,Abbott Diana,Minhajuddin Mohd,Jordan Craig,Pollyea Daniel A.^ORCID,Gutman Jonathan A.^ORCID

Funder

Swim Across America

National Institutes of Health

Morgan Adams Foundation

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference40 articles.

1. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia;Venditti;Blood,2019

2. Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms;Halpern;Leukemia,2018

3. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials;Koreth;JAMA,2009

4. Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis;Stelljes;J Clin Oncol,2014

5. Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study;Ustun;Leukemia,2019

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?;Leukemia & Lymphoma;2024-07-23

2. Advancements and Challenges in the Treatment of AML;American Society of Clinical Oncology Educational Book;2024-06

3. Tailoring Therapy in Older Adults With Hematologic Malignancies;American Society of Clinical Oncology Educational Book;2024-06

4. Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation;Cancer;2024-05-29

5. Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia;British Journal of Haematology;2024-04-11